Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

01 July 2020
Pharma

Visiongain has launched a new pharma report Clinical Risk Grouping Solutions Market Report 2020-2030: Forecasts by Product (Dashboard Analytics Solutions, Risk Reporting Solutions, Scorecards & Visualization Tools), Deployment Model (Hybrid Cloud, Private Cloud, Public Cloud), End User (Ambulatory Care Centers, Hospitals, Long-Term Care Centers, Payers, Other End Users), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).

The global clinical risk grouping solutions market is anticipated to grow at a lucrative CAGR of ~xxx% and anticipated to reach USD xxx million by 2020 owing to the growing focus on patient’s risk management and implementation of big data in the healthcare industry to transform clinical outcomes.

To access the data contained in this document please email contactus@visiongain.com

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care. Also, accuracy in risk assessment and growing investments in R&D of new therapeutics is anticipated to boost the market growth over the forecast period. Furthermore, the compilation of patient information in healthcare settings, resulting in physician burden is increasing the demand for clinical risk grouping solutions.

However, lack of skilled professionals, concerns regarding the private cloud data management, and high costs related to management solutions are projected to hamper the market growth over the forecast period.

North America dominated the global clinical risk grouping solutions market owing to the presence of developed healthcare infrastructure. Also, the market will continue to be driven by the rising support for the adoption of healthcare information technology (HCIT) by payers and providers. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to the growing demand for developed healthcare facilities, growing government initiatives to manage the health of the growing population across markets such as India and China. Additionally, unmet needs of patients and untapped nations in this region have been attracting investments by global players and this is expected to boost the clinical risk grouping solutions market growth over the forecast period.

Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global clinical risk grouping solutions market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the clinical risk grouping solutions market.

For instance, in June 2019, Health Catalyst announced the launch of the “Population Health Foundations” solution. This launch is an up-gradation of the existing population health technology provided by the organization which will help in the provision of valuable insights and analytical views which are of utmost importance for the succession of an organization while providing value-focused healthcare services

The comprehensive market report features companies such as 3M Company, 4S Information Systems Ltd., Cerner Corporation, Conduent Incorporated, Dynamic Healthcare Systems, Inc., Evolent Health, HBI Solutions, Inc., Health Catalyst Inc., Johns Hopkins University, Lightbeam Health Solutions, LLC, Nuance Communications, Optum Inc, Perahealth, Inc. among other prominent players. Also, the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

Read

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

Read

Visiongain Publishes Clinical Perinatal Software Market Report 2020-2030

Various research studies are currently underway, which are expected to create a competitive advantage for manufacturers to develop new and innovative and advanced software that is expected to provide a variety of additional opportunities in the perinatal clinical software market.

01 July 2020

Read

Visiongain publishes Clinical Laboratory Tests Market Report 2020-2030

Growing investment in target diagnosis of cardiovascular disorders, TB and diabetes drives demand for clinical laboratory testing. Clinical lab tests help in diagnosing mellitus diabetes. According to the International Diabetes Federation article published in 2019, some 463 million adults were diabetic, and it is estimated that it will reach 700 million worldwide by 2045.

01 July 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever